Fundraising FoxToetal Solutions
Malvern, US · Founded 2020 · Delaware corporation
Find your way into Toetal Solutions
Sign up to see every warm intro you have to Toetal Solutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Toetal Solutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Toetal Solutions is a medical device company operating in the foot and ankle (podiatric/orthopedic) space, backed by the Runway Healthcare portfolio. The team combines medical device operators and podiatric surgeons focused on lower extremity treatment.
Founders & leadership
Toetal Solutions was founded in 2020 by Nicholas Pachuda.
NP
Nicholas PachudaFounder
JF
Jeffrey F. O'Donnell, Jr.Co-Founder, Chief Executive Officer, and Board MemberJeffrey O'Donnell Jr. brings over fifteen years of healthcare device development experience, having led musculoskeletal and cardiovascular platforms through regulatory clearance and acquisition. He serves as Chief Operating Officer of Runway Investment Management and CEO of its portfolio companies, including Toetal Solutions, and holds a degree from the Haub School of Business at Saint Joseph's University.
SP
Stephen P. BancoExecutive
WO
William OdenthalExecutive
JF
Jeffrey F. O'Donnell, Sr.Executive
JO
Jeff O'Donnell, Jr.CEO
Board
WS
Reported raises · per SEC filings
Form D private placements$4.8M disclosed across 9 rounds · 2021–2026
▶$50KraisedSep 2026 · 1 investors · Other Health CareRule 506(b)
▶$50KraisedSep 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey F O'Donnell, Sr.Executive Officer, Director
- William John OdenthalExecutive Officer, Director
- William Scott RhodaExecutive Officer, Director
- Jeffrey F. O'Donnell, Jr.Executive Officer, Director
- Nicholas PachudaDirector
- Offering amount
- $250K
- Amount sold
- $50K
- First sale
- Sep 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$100KraisedApr 2026 · 1 investors · Other Health CareRule 506(b)
▶$100KraisedApr 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey F. O'Donnell, Jr.Executive Officer, Director
- Nicholas PachudaDirector
- William Scott RhodaExecutive Officer, Director
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- William John OdenthalExecutive Officer, Director
- Offering amount
- $100K
- Amount sold
- $100K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$950.7KraisedDec 2024 · 16 investors · Other Health CareRule 506(b)
▶$950.7KraisedDec 2024 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William John OdenthalExecutive Officer, Director
- William Scott RhodaExecutive Officer, Director
- Jeffrey F. O'Donnell, Jr.Executive Officer, Director
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- Nicholas PachudaDirector
- Offering amount
- $1M
- Amount sold
- $950.7K
- Sales commissions
- $39K
- Proceeds to insiders
- $225K
- Placement agents
- "Alere Financial Partners, A division of Cova Capital Partners LLC (""Alere""))"
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$100KraisedSep 2024 · 1 investors · Other Health CareRule 506(b)
▶$100KraisedSep 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey F. O'Donnell, JrExecutive Officer, Director
- William Scott RhodaDirector
- Stephen P. BancoExecutive Officer, Director
- William OdenthalExecutive Officer, Director
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- Offering amount
- $100K
- Amount sold
- $100K
- Proceeds to insiders
- $35K
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$430KraisedMay 2024 · 11 investors · Other Health CareRule 506(b)
▶$430KraisedMay 2024 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas PachudaDirector
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- William Scott RhodaExecutive Officer, Director
- William John OdenthalExecutive Officer, Director
- Jeffrey F. O'Donnell, Jr.Executive Officer, Director
- Offering amount
- $600K
- Amount sold
- $430K
- Sales commissions
- $19.8K
- Proceeds to insiders
- $100K
- Placement agents
- Cova Capital Partners LLC
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$150KraisedDec 2023 · 1 investors · Other Health CareRule 506(b)
▶$150KraisedDec 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas PachudaDirector
- William Scott RhodaExecutive Officer, Director
- William John OdenthalExecutive Officer, Director
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- Jeffrey F. O'Donnell, Jr.Executive Officer, Director
- Offering amount
- $150K
- Amount sold
- $150K
- Proceeds to insiders
- $30K
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1.8MraisedOct 2022 · 20 investors · Other Health CareRule 506(b)
▶$1.8MraisedOct 2022 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William Scott RhodaExecutive Officer, Director
- William OdenthalExecutive Officer, Director
- Jeffrey F. O'Donnell, Jr.Executive Officer, Director
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- Nicholas PachudaDirector
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- Sales commissions
- $76.5K
- Proceeds to insiders
- $350K
- Placement agents
- Cova Capital Partners LLC
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$800KraisedMar 2022 · 1 investors · Other Health CareRule 506(b)
▶$800KraisedMar 2022 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- William John OdenthalExecutive Officer, Director
- Nicholas PachudaDirector
- William Scott RhodaExecutive Officer, Director
- Jeffrey F. O'Donnell, Jr.Executive Officer, Director
- Offering amount
- $800K
- Amount sold
- $800K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Toetal Solutions do?
- Toetal Solutions is a medical device company operating in the foot and ankle (podiatric/orthopedic) space, backed by the Runway Healthcare portfolio. The team combines medical device operators and podiatric surgeons focused on lower extremity treatment.
- Who founded Toetal Solutions?
- Toetal Solutions was founded by Nicholas Pachuda in 2020.
- How much funding has Toetal Solutions raised?
- Toetal Solutions has disclosed $4.8M raised across 9 rounds.
- Where is Toetal Solutions headquartered?
- Toetal Solutions is headquartered in Malvern, US.